One dose of a bivalent or nonavalent HPV vaccine was noninferior to two doses, the randomized ESCUDDO trial found. Vaccine ...

(HealthDay News) — One dose of bivalent or nonavalent human papillomavirus (HPV) vaccine is noninferior to 2 doses for protecting against HPV16 and HPV18 infection, according to a study published ...

Previous trials have shown that a one-dose regimen of the HPV vaccine may be as effective as two- and three-dose regimens, ...

GARDASIL 9 prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects.

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine ...

SEATTLE — Since its approval by the U.S. Food and Drug Administration in 2006, the HPV vaccine has made considerable strides in preventing cervical and oropharyngeal, or throat cancers. HPV, short for ...

Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as the current multi-dosing schedule, the drugmaker said that an alternative ...

V503-064 is a Phase 3, double-blind, placebo-controlled clinical study (NCT04635423) to evaluate the safety/tolerability and efficacy of GARDASIL 9 (V503) in preventing HPV-related anogenital ...

Merck (NYSE:MRK) announced Wednesday plans to conduct clinical trials to evaluate the efficacy and safety of a single-dose regimen of its human papillomavirus (HPV) vaccine, Gardasil 9. "In response ...

March 13 (Reuters) - Merck & Co MRK.N said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a ...